190 related articles for article (PubMed ID: 31142011)
1. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes.
On S; Kim HY; Kim HS; Park J; Kang KW
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142011
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120).
Kang S; Huang J; Lee BK; Jung YS; Im E; Koh JM; Im DS
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):105-116. PubMed ID: 29126901
[TBL] [Abstract][Full Text] [Related]
3. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
5. Oleate activates SREBP-1 signaling activity in
Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
[TBL] [Abstract][Full Text] [Related]
6. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.
Choi YJ; Shin HS; Choi HS; Park JW; Jo I; Oh ES; Lee KY; Lee BH; Johnson RJ; Kang DH
Lab Invest; 2014 Oct; 94(10):1114-25. PubMed ID: 25111690
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
8. Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells.
Ting TC; Miyazaki-Anzai S; Masuda M; Levi M; Demer LL; Tintut Y; Miyazaki M
J Biol Chem; 2011 Jul; 286(27):23938-49. PubMed ID: 21596756
[TBL] [Abstract][Full Text] [Related]
9. Docosapentaenoic acid (22:5n-3) down-regulates the expression of genes involved in fat synthesis in liver cells.
Kaur G; Sinclair AJ; Cameron-Smith D; Barr DP; Molero-Navajas JC; Konstantopoulos N
Prostaglandins Leukot Essent Fatty Acids; 2011; 85(3-4):155-61. PubMed ID: 21807486
[TBL] [Abstract][Full Text] [Related]
10. The role of LXR alpha in goose primary hepatocyte lipogenesis.
Han C; Wang J; Li L; Wang L; Zhang Z
Mol Cell Biochem; 2009 Feb; 322(1-2):37-42. PubMed ID: 18975056
[TBL] [Abstract][Full Text] [Related]
11. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.
Shimano H; Yahagi N; Amemiya-Kudo M; Hasty AH; Osuga J; Tamura Y; Shionoiri F; Iizuka Y; Ohashi K; Harada K; Gotoda T; Ishibashi S; Yamada N
J Biol Chem; 1999 Dec; 274(50):35832-9. PubMed ID: 10585467
[TBL] [Abstract][Full Text] [Related]
12. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
[TBL] [Abstract][Full Text] [Related]
13. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
14. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
[TBL] [Abstract][Full Text] [Related]
15. GPR119: a promising target for nonalcoholic fatty liver disease.
Yang JW; Kim HS; Im JH; Kim JW; Jun DW; Lim SC; Lee K; Choi JM; Kim SK; Kang KW
FASEB J; 2016 Jan; 30(1):324-35. PubMed ID: 26399788
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
17. Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element.
Caputo M; De Rosa MC; Rescigno T; Zirpoli H; Vassallo A; De Tommasi N; Torino G; Tecce MF
Cell Biochem Funct; 2014 Dec; 32(8):637-46. PubMed ID: 25264165
[TBL] [Abstract][Full Text] [Related]
18. The effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitro.
Zhao F; Xie P; Jiang J; Zhang L; An W; Zhan Y
Int J Mol Sci; 2014 Mar; 15(3):4019-30. PubMed ID: 24603540
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling.
Seo MH; Lee J; Hong SW; Rhee EJ; Park SE; Park CY; Oh KW; Park SW; Lee WY
PLoS One; 2016; 11(12):e0166913. PubMed ID: 27907035
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P
Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
